Annandale Capital’s AbbVie ABBV Stock Holding History

Annandale Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.05M	Hold	28,032	–	–	0.96%	31
2026 Q1	$6.1M	Buy	28,032 +12	+0%	+$2.66K	0.86%	34
2025 Q4	$6.4M	Sell	28,020 -702	-2%	-$160K	0.76%	36
2025 Q3	$6.65M	Sell	28,722 -338	-1%	-$68.8K	1.13%	26
2025 Q2	$5.39M	Sell	29,060 -80	-0.3%	-$14.9K	0.41%	34
2025 Q1	$6.11M	Hold	29,140	–	–	0.39%	35
2024 Q4	$5.18M	Buy	29,140 +34	+0.1%	+$6.25K	0.82%	35
2024 Q3	$5.75M	Hold	29,106	–	–	0.81%	30
2024 Q2	$4.99M	Buy	29,106 +25,406	+687%	+$4.21M	0.85%	29
2024 Q1	$674K	Hold	3,700	–	–	0.12%	84
2023 Q4	$573K	Hold	3,700	–	–	0.11%	91
2023 Q3	$552K	Hold	3,700	–	–	0.14%	80
2023 Q2	$499K	Sell	3,700 -65	-2%	-$9.53K	0.14%	87
2023 Q1	$600K	Hold	3,765	–	–	0.19%	79
2022 Q4	$608K	Sell	3,765 -377	-9%	-$57.8K	0.2%	80
2022 Q3	$556K	Sell	4,142 -35	-0.8%	-$5.02K	0.21%	80
2022 Q2	$640K	Hold	4,177	–	–	0.25%	68
2022 Q1	$677K	Hold	4,177	–	–	0.27%	66
2021 Q4	$566K	Hold	4,177	–	–	0.25%	70
2021 Q3	$451K	Hold	4,177	–	–	0.27%	58
2021 Q2	$470K	Sell	4,177 -2	-0%	-$225	0.28%	59
2021 Q1	$452K	Sell	4,179 -54	-1%	-$5.78K	0.32%	43
2020 Q4	$454K	Buy	+4,233	New	+$407K	0.38%	33

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Annandale Capital's ABBV Position: Q2 2026 in Review

Annandale Capital held its AbbVie (ABBV) position steady in Q2 2026 at 28,032 shares worth $7.05M. The position accounts for 0.96% of the portfolio, ranked #31.

Annandale Capital first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Annandale Capital held 28,032 shares of AbbVie worth $7.05M as of Q2 2026.
Annandale Capital left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.96% of Annandale Capital's portfolio in Q2 2026, its #31 holding.
Annandale Capital first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Annandale Capital's 13F filing for Q2 2026, filed 13 Aug 2026.